Results 91 to 100 of about 11,988 (216)
Reinstitution of diet therapy in PKU patients from twenty-two US clinics.
, 1985 V E Schuett +2 more
openalex +2 more sources
Defining tetrahydrobiopterin (BH4)‐responsiveness in PKU [PDF]
, 2008 Nenad Blau
openalex +1 more source
119. Long-Term Correction of Hyperphenylalaninemia in a Mouse Model for PKU by Intramuscular Delivery of AAV Expressing PAH with Serotypes 1, 2 or 8 [PDF]
, 2008 openalex +1 more source
The financial and time burden associated with phenylketonuria treatment in the United States
Molecular Genetics and Metabolism Reports, 2019 Background: Phenylketonuria (PKU) imposes a substantial burden on people living with the condition and their families. However, little is known about the time cost and financial burden of having PKU or caring for a child with the condition.
Angela M. Rose +6 more
doaj
172. Therapeutic Thresholds for Liver-Directed Gene Therapy of Phenylketonuria (PKU) [PDF]
, 2009 openalex +1 more source
Molecular Genetics and Metabolism ReportsThe first cohort of early-treated adults with phenylketonuria (PKU) is reaching middle-age and moving towards old age. We do not know if and how the effects of an aging brain may interact with the effect of PKU.
Lucie Thomas +5 more
doaj
Radiopharmaceutical Chemistry in Peking University (PKU)
, 2000 Xiangyun Wang +3 more
openalex +2 more sources
Large neutral amino acids in the treatment of PKU: from theory to practice [PDF]
, 2010 Francjan J. van Spronsen +4 more
openalex +1 more source
Retraction to “Correction in Female PKU Mice by Repeated Administration of mPAH cDNA Using phiBT1 Integration System” [PDF]
, 2010 openalex +1 more source